Best Biopharma Outsourcing Companies in Colorado, United States
The 30 best Biopharma Outsourcing companies in Colorado, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: STAQ Pharma.
Our analysis of 50 Biopharma Outsourcing companies
$6.3b in tracked funding; 77% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Colorado
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | STAQ Pharma Provider of drug discovery services | $34M | 26 mo ago | Series D | — | 2018 | WordPress Block EditorWordPressApple iCloud Mail+22 | — | — |
| 2 | Evio Provider of pharmacy supply chain services | $9M | 20 mo ago | Series A | — | 2003 | WebflowSplidejQuery+10 | — | — |
| 3 | Corgenix Diagnostic tests for vascular diaseases | $6M | 154 mo ago | Acquired | Werner Hofacher CEO | 1990 | — | — | — |
| 4 | New Iridium Manufacturer of phenoxazine and dihydrophenazine 24Talent top 28%Funding top 39%Global bottom 29%Market bottom 19% All 4 signals ▾Talenttop 28% Fundingtop 39% Globalbottom 29% Marketbottom 19% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated Funding: Raised $6.1M across 6 rounds · 6 rounds over 6 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 24/100 | $6M | 17 mo ago | Seed | Garrett Miyake Co-Founder & CTO | 2016 | — | — | — |
| 5 | Pyxant CRO offering analytical and laboratory services for drug development | $4M | 112 mo ago | Acquired | — | 1984 | — | — | — |
| 6 | Aliri CRO focused on drugs discovery, method development, and validation services | $1M | 70 mo ago | Series A | — | 2009 | WordPressMySQLPHP+29 | — | — |
| 7 | Plato BioPharma Provider of in vivo studies and also offering biochemical, biomarker, and histology services | $600K | 198 mo ago | Acquired | Craig Plato Founder & CEO | 2010 | — | — | — |
| 8 | WiTii Pharmaceutical firm focused drugs development and consulting services | $125K | 29 mo ago | Seed | Anand Shukla Founder | 2021 | — | — | — |
Top 9 Biopharma Outsourcing companies in Colorado
#1
Seed · Boulder, Colorado · founded 2016 · 11 employees$6.1Mraised▾
Manufacturer of phenoxazine and dihydrophenazine
- Jun 2025Seed$2.6M
- Jul 2024Grant (prize money)$200K
- Jun 2023Grant (prize money)$1M
- May 2020Grant (prize money)$256K
#2
Series A · Denver, Colorado · founded 2003 · 23 employees$8.5Mraised▾
Provider of pharmacy supply chain services
- Feb 2025Series A$8.5M
#3
Series D · Denver, Colorado · founded 2018 · 30 employees$33.5Mraised▾
Provider of drug discovery services
- Sep 2024Series D$11.4M
- Apr 2023Series C$10.1M
- Mar 2022Series C—
- Mar 2021Series B$9M
#4
Seed · Denver, Colorado · founded 2021$125Kraised▾
WiTii Pharma Consulting is a global pharmaceutical consulting firm that focuses on the rising demand for generics in the U.S. prescription drug market. Their team takes bold risks and embraces entrepreneurial uncertainty to provide valuable advice to drug manufacturers.
- Jun 2024Seed$125K
#5
Acquired · Broomfield, Colorado · founded 1990 · 24 employees$6.4Mraised▾
Diagnostic tests for vascular diaseases
- Jan 2014Grant (prize money)—
- Jul 2010Post IPO$1.2M
- Apr 2010Grant (prize money)$3.6M
- Mar 2010Grant (prize money)$590.2K
#6
Acquired · Colorado Springs, Colorado · founded 1984 · 122 employees$4.1Mraised▾
Pyxant Labs is a contract research laboratory specializing in GLP bioanalytical chemistry support for life sciences clients. Services offered include Picogram-level bioanalytical method development, also including validation and optimization, assay development, metabolism and toxicology bioanalytical support, and a wide range of sample preparation experience, and pharmaceutical and bioequivalence support. The company also has a CLIA Clinical Laboratory Services (CLS) division that offers assay services for a range of patient specimens including urine and oral fluids.
- Jul 2017Unattributed$1.1M
- Mar 2014Unattributed$690K
- Aug 2007Unattributed$240K
- May 2006Unattributed$350K
#7
Series A · Colorado Springs, Colorado · founded 2009 · 22 employees$1.2Mraised▾
CRO focused on drugs discovery, method development, and validation services
- Jan 2021Grant (prize money)$337K
- 2014Series A$1.2M
#8
Acquired · Westminster, Colorado · founded 2010 · 34 employees$600Kraised▾
Plato BioPharma offers in-vitro and in vivo testing services mainly in the cardiovascular, renal, pulmonary, diabetes and hepatic therapeutic areas. The company has capabilities for conducting physiological evaluation of disease models, acute and chronic assessment of in vivo responses and for evaluating histologic and biomarker responses across cells, tissues and organs. Plato claims to have expertise in small animal studies with capabilities for small animal surgery, compound administration in a wide range of dosage forms, necropsy, among others. Their biomarker and in vitro biology services include immunoassays, biochemical assays, ex vivo myograph tension recording etc.
- May 2010Conventional Debt—
- May 2010Seed$600K
#9
Acquired · Denver, Colorado · founded 1987 · 214 employees—raised▾
Pharmatech is an oncology focused CRO cum SMO offering clinical development services for the pharma and the biotech industries. The company claims to have significant expertise in enrollment and timeline management and offers a unique Just-In-Time service for rapid study start-up, which as per company claims can go from patient pre-identification to enrollment within 10 days (average). The company manages an oncology network of more than 340 sites and 2,200 investigators. Their service portfolio includes site management, study start-up, study rescue, investigator sponsored trials. The company uses a proprietary tech platform/communication tool for communicating between its team of 2,200 investigators and research staff.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising